Calendar Oncopeptides AB

Equities

ONCO

SE0009414576

Delayed Nasdaq Stockholm 07:59:33 2024-03-28 am EDT 5-day change 1st Jan Change
6.5 SEK -2.40% Intraday chart for Oncopeptides AB +45.51% -15.14%

Chart calendar Oncopeptides AB

ed216585ffa5b2b4aeaa0e88991b.m5M6-IbVbSx6PjL2W-xVmJZuXyAtExEGUF5WBCZQWkA.ydVrp-WKCG8xdXqBDJQm9NsJPRBjdyRjYxQuaWlhLzfM0Wme_60iXh9cWQ~6a1eb76473a9ade2d6ba7f8ffe70d4a5

Upcoming events on Oncopeptides AB

2024-05-03 02:00 am Q1 2024 Earnings Release
2024-05-21 Annual General Meeting
2024-08-14 02:00 am Q2 2024 Earnings Release
2024-11-07 02:00 am Q3 2024 Earnings Release
2025-02-12 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)
2025-08-26 Q2 2025 Earnings Release (Projected)
2025-11-18 Q3 2025 Earnings Release (Projected)

Past events on Oncopeptides AB

2024-03-20 06:30 am Redeye Theme: Commercialization in Life Science
2024-02-27 03:00 am Q4 2023 Earnings Call
2024-02-27 02:00 am Q4 2023 Earnings Release
2024-01-24 07:07 am Redeye Theme: Fight Cancer
2023-11-08 03:00 am Q3 2023 Earnings Call
2023-11-08 02:00 am Q3 2023 Earnings Release
2023-08-10 03:00 am Q2 2023 Earnings Call
2023-08-10 02:00 am Q2 2023 Earnings Release
2023-05-25 09:00 am Annual General Meeting
2023-05-04 03:00 am Q1 2023 Earnings Call
2023-05-04 02:00 am Q1 2023 Earnings Release
2023-02-16 03:00 am FY 2022 Earnings Call
2023-02-16 02:00 am FY 2022 Earnings Release
2022-12-09 American Society of Hematology Meeting - Poster No. 4799
2022-12-09 American Society of Hematology Meeting - Poster No. 2673
2022-12-09 American Society of Hematology Meeting - Abstract No. 5776
2022-12-09 American Society of Hematology Meeting - Poster No. 4800
2022-11-22 SEB Healthcare Seminar
2022-11-09 08:00 am Q3 2022 Earnings Call
2022-11-09 03:18 am Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million SEK
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
7,60
-
118
156
-24.22%
8,36
6,88
21.53%
35,2
38,8
-9.31%
EBITDA
Million SEK
Released
Forecast
Spread
-419
-421
0.46%
-735
-678
-8.39%
-1 577
-1 495
-5.51%
-1 400
-1 411
0.81%
-332
-319
-4.15%
0,00
-241
-
EBIT
Million SEK
Released
Forecast
Spread
-419
-421
0.41%
-739
-685
-7.97%
-1 591
-1 494
-6.5%
-1 421
-1 331
-6.72%
-349
-319
-9.53%
-253
-234
-8.51%
Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-419
-416
-0.78%
-740
-684
-8.16%
-1 592
-1 495
-6.54%
-1 421
-1 332
-6.7%
-338
-319
-5.87%
-248
-236
-5.26%
Net income
Million SEK
Released
Forecast
Spread
-419
-416
-0.82%
-741
-684
-8.25%
-1 595
-1 481
-7.7%
-1 430
-1 302
-9.85%
-338
-319
-5.95%
-249
-236
-5.54%
EPS
SEK
Released
Forecast
Spread
-9,77
-9,88
1.11%
-14,3
-13,6
-5.76%
-25,6
-23,3
-9.75%
-19,0
-17,9
-6.31%
-4,11
-3,63
-13.13%
-2,76
-2,07
-33.18%
Announcement Date22/02/1920/02/2018/02/2117/02/2216/02/2324/02/24

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales
Million SEK
Released
Forecast
Spread
54,3
93,3
-41.85%
-21,7
32,6
-166.63%
0,00
22,7
-
8,75
0,00
-
0,00
0,00
-
EBIT
Million SEK
Released
Forecast
Spread
-339
-337
-0.5%
-390
-168
-131.88%
-98,9
-162
39.11%
-61,1
-66,0
7.38%
-88,9
-59,7
-48.79%
Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-339
-338
-0.18%
-389
-168
-131.67%
-98,6
-162
39.28%
-59,6
-66,0
9.7%
-88,3
-59,7
-47.91%
Net income
Million SEK
Released
Forecast
Spread
-778
-338
-130.08%
-394
-168
-134.35%
-98,6
-162
39.28%
-59,8
-66,0
9.28%
-88,4
-59,7
-48.1%
EPS
SEK
Released
Forecast
Spread
-10,3
-4,49
-130.07%
-5,23
-2,22
-135.59%
-1,31
-2,15
39.07%
-0,79
-0,87
9.2%
-1,00
-0,72
-38.89%
Announcement Date24/11/2117/02/2204/05/2211/08/2209/11/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise